284 related articles for article (PubMed ID: 30411792)
1. Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.
Yuan C; Shui IM; Wilson KM; Stampfer MJ; Mucci LA; Giovannucci EL
Int J Cancer; 2019 May; 144(10):2401-2407. PubMed ID: 30411792
[TBL] [Abstract][Full Text] [Related]
2. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.
Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT
Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684
[TBL] [Abstract][Full Text] [Related]
3. Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer.
Ying HQ; Sun HL; He BS; Pan YQ; Wang F; Deng QW; Chen J; Liu X; Wang SK
Sci Rep; 2015 Jan; 5():7956. PubMed ID: 25609140
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
Yang L; Chen H; Zhao M; Peng P
Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer.
Yuan C; Song M; Zhang Y; Wolpin BM; Meyerhardt JA; Ogino S; Hollis BW; Chan AT; Fuchs CS; Wu K; Wang M; Smith-Warner SA; Giovannucci EL; Ng K
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2323-2331. PubMed ID: 32917664
[TBL] [Abstract][Full Text] [Related]
7. Relationships between Total, Free and Bioavailable Vitamin D and Vitamin D Binding Protein in Early Pregnancy with Neonatal Outcomes: A Retrospective Cohort Study.
Fernando M; Coster TG; Ellery SJ; Guingand D; Lim S; Harrison CL; Teede HJ; Naderpoor N; Mousa A
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32824958
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.
Weinstein SJ; Mondul AM; Kopp W; Rager H; Virtamo J; Albanes D
Int J Cancer; 2013 Jun; 132(12):2940-7. PubMed ID: 23180681
[TBL] [Abstract][Full Text] [Related]
10. Critically Ill Children Have Low Vitamin D-Binding Protein, Influencing Bioavailability of Vitamin D.
Madden K; Feldman HA; Chun RF; Smith EM; Sullivan RM; Agan AA; Keisling SM; Panoskaltsis-Mortari A; Randolph AG
Ann Am Thorac Soc; 2015 Nov; 12(11):1654-61. PubMed ID: 26356094
[TBL] [Abstract][Full Text] [Related]
11. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
[TBL] [Abstract][Full Text] [Related]
12. The association of serum vitamin D-binding protein and 25-hydroxyvitamin D in pre-operative and post-operative colorectal cancer.
Liang Y; Jiang L; Chi X; Hochwald S; Qiu F; Luo Y; Lu Q; Yang X; Huang H; Xu J
J Clin Lab Anal; 2020 May; 34(5):e23154. PubMed ID: 31837045
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.
Sawada N; Inoue M; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Tsugane S
Eur J Clin Nutr; 2017 Jan; 71(1):132-136. PubMed ID: 27759068
[TBL] [Abstract][Full Text] [Related]
14. Distribution and Determinants of Vitamin D-Binding Protein, Total, "Non-Bioavailable", Bioavailable, and Free 25-Hydroxyvitamin D Concentrations among Older Adults.
Zhu A; Kuznia S; Niedermaier T; Holleczek B; Schöttker B; Brenner H
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836237
[TBL] [Abstract][Full Text] [Related]
15. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
[TBL] [Abstract][Full Text] [Related]
16. Total, bioavailable and free 25-hydroxyvitamin D are associated with the prognosis of patients with non-small cell lung cancer.
Peng SM; Yu N; Che J; Xu JY; Chen GC; Li DP; Zhang YS; Qin LQ
Cancer Causes Control; 2022 Jul; 33(7):983-993. PubMed ID: 35411490
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral contraceptives on total and bioavailable 25-hydroxyvitamin D.
Stanczyk FZ; Sriprasert I; Danis R; Pandian R; Matharu H; Bender N; Natavio M
J Steroid Biochem Mol Biol; 2021 Jul; 211():105879. PubMed ID: 33757895
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.
Miles FL; Goodman PJ; Tangen C; Torkko KC; Schenk JM; Song X; Pollak M; Thompson IM; Neuhouser ML
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28417914
[TBL] [Abstract][Full Text] [Related]
19. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
